Takeda Beats Rivals' Challenge To Diabetes Drug Patent
Takeda Pharmaceuticals Ltd. defeated a bid by two generic-drug makers to invalidate a patent for its brand-name Type II diabetes treatments when a New Jersey federal judge said there was no...To view the full article, register now.
Already a subscriber? Click here to view full article